Cadila starts clinical trial of Saroglitazar in USA
Leading pharmaceuticals company Cadila Healthcare with the support from USFDA has announced for the beginning of phase 2 of clinical trial of Saroglitazar in the patients who are suffering from severe Hypertriglyceridemia in USA.
Gammon up on receiving nod to transfer civil EPC biz
Gammon India gained over 6%, touching to Rs12.83, after the company's board of directors transacted the business of transfer of Civil Engineering, Procurement and Construction business to Gammon Retail Infrastructure
Marico to use the recent acquisition of Bellezimo
Marico recently picked up a 45% stake in Mumbai-based start-up Bellezimo Professionale Products for an estimated Rs10 crore. Marico will use the acquisition to focus on the salon distribution channel to increase the distribution of its hair care products (including hair cream, hair cerum and value added hair oil).
HCL wins two 2015 CA Technologies Partner Awards
HCL Technologies was named the winner of CA Partner of the Year awards in the category of innovation and sales teaming. The winners were announced at the CA World '15 Partner Awards Ceremony held in Las Vegas.
Dishman Pharma climbs after clarification on Clovis issue
Dishman Pharmaceuticals surged nearly 6%, touching to Rs344.55, after the company has clarified that it has not received any warning from the United States Food and Drug Administration ( USFDA) on Clovis issue.
0 Comments